NIH is ‘very concerned’ about serious side effect in coronavirus vaccine trial
4 years, 3 months ago

NIH is ‘very concerned’ about serious side effect in coronavirus vaccine trial

LA Times  

AstraZeneca’s coronavirus vaccine trial was allowed to resume in Britain, but authorities in the U.S. are still investigating the case of a patient who suffered a serious illness. The National Institutes of Health has launched an investigation into the case of a patient who suffered spinal cord damage after joining AstraZeneca’s coronavirus vaccine trial. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal of uncertainty remains about what happened to the unnamed patient. “It’s very, very hard” to determine if one rare event was caused by a vaccine, Schaffner said.

Health Trial Information British Case Covid More Information Study Patient Fda Vaccine Goodman Astrazeneca Nih Schaffner Transverse Myelitis Coronavirus Vaccine Trial  study  effect  patient  coronavirus  concerned  health  astrazeneca  trial  spinal  serious  vaccine  goodman  information  case  nih

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
8 months ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
8 months ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know
1 year, 2 months ago

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know

Daily Mail  

As Brits take AstraZeneca to court we recount what happened with the Covid jab AstraZeneca's Covid vaccine undoubtedly saved millions of lives. AstraZeneca's Covid jab timeline January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a 'Public Health Emergency of International Concern' March 2020: Then Prime Minister …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 3 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

Urgently Trying to Work with AstraZeneca, SII, Indian Govt to Restart Covid-19 Vaccine Shipments: WHO Official
3 years, 6 months ago

Urgently Trying to Work with AstraZeneca, SII, Indian Govt to Restart Covid-19 Vaccine Shipments: WHO Official

News 18  

The WHO is urgently trying to work with AstraZeneca, Serum Institute of India as well as the Indian government to restart shipments of COVID-19 vaccines to countries that had to suspend the rollout of second doses of vaccines amid the disruption in supplies, a senior official at the UN health agency has said. “We have a huge number of countries …

U.S. to spend $ 3.2 billion to develop treatments for COVID-19 and potential threats
3 years, 6 months ago

U.S. to spend $ 3.2 billion to develop treatments for COVID-19 and potential threats

The Hindu  

The United States has announced that it will spend $ 3.2 billion on developing antiviral treatments for COVID-19 and prepare for other “pandemic threats” – viruses that have the potential to cause pandemics. Watch | Dr. Anthony Fauci on the second wave of COVID-19 in India, mucormycosis and more “Vaccines will continue to remain the ‘centrepiece of our arsenal’ against …

Coronavirus vaccine advice on AstraZeneca has changed again — here's what it means for under-60s
3 years, 6 months ago

Coronavirus vaccine advice on AstraZeneca has changed again — here's what it means for under-60s

ABC  

The Pfizer vaccine is now the preferred coronavirus jab for Australians under 60, after medical experts re-assessed the risks posed by the AstraZeneca inoculation. But in the past week, seven out of 12 people in Australia who developed TTS after the AstraZeneca vaccine were in the 50-59 age group. "And so people over 60 should still be rolling out to …

Britain Seeks Extra AstraZeneca Shots to Combat 'Beta' Covid-19 Variant
3 years, 7 months ago

Britain Seeks Extra AstraZeneca Shots to Combat 'Beta' Covid-19 Variant

News 18  

Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the “beta” coronavirus variant first identified in South Africa, and it will fund trials of the shots. Britain has previously secured 100 million doses of the vaccine, developed at the University of Oxford and licenced to AstraZeneca, and …

AstraZeneca refuseniks will be offered a different vaccine: minister
3 years, 7 months ago

AstraZeneca refuseniks will be offered a different vaccine: minister

Dutch News  

People in their early 60s who refused an AstraZeneca coronavirus vaccine will be offered an alternative in the near future after all, health minister Hugo de Jonge has told MPs. This time round they will be called up by their local health board rather than family doctor and will be given either a Pfizer, Moderna or Janssen vaccine, De Jonge …

India plans to study effectiveness of AstraZeneca, Bharat Biotech vaccines
3 years, 7 months ago

India plans to study effectiveness of AstraZeneca, Bharat Biotech vaccines

Live Mint  

India's main health agency will start a study next week to examine the effectiveness of AstraZeneca's vaccine and the homegrown shot Covaxin against coronavirus, a scientist said on Wednesday. "The main objective is to find out whether the vaccine prevents severe disease," Tarun Bhatnagar told Reuters in a phone interview from the National Institute of Epidemiology in Chennai, which will …

Coronavirus | 20 given wrong second COVID-19 vaccine dose in U.P. village
3 years, 7 months ago

Coronavirus | 20 given wrong second COVID-19 vaccine dose in U.P. village

The Hindu  

In a major lapse, 20 villagers in the eastern Uttar Pradesh district of Siddharthnagar were administered the Covishield vaccine in their first dose but given a Covaxin shot in the second. Scientists at the Oxford Vaccine Group, United Kingdom have been studying if mixing the Pfizer and AstraZeneca doses could confer longer-lasting immunity, better protection against emerging variants or allow …

Most of the AstraZeneca coronavirus vaccines on order 'won't be used'
3 years, 8 months ago

Most of the AstraZeneca coronavirus vaccines on order 'won't be used'

Dutch News  

The head of the vaccination department at public health institute RIVM has been criticised after telling the AD in an interview that the millions of doses of the AstraZeneca vaccine due to reach the Netherlands in the coming weeks will largely remain unused. So many vaccines will be delivered that the AstraZeneca vaccine, currently only given to people aged 60 …

Most of the AstraZeneca coronavirus vaccines on order 'won't be used'
3 years, 8 months ago

Most of the AstraZeneca coronavirus vaccines on order 'won't be used'

Dutch News  

The head of the vaccination department at public health institute RIVM has been criticised after telling the AD in an interview that the millions of doses of the AstraZeneca vaccine due to reach the Netherlands in the coming weeks will largely remain unused. So many vaccines will be delivered that the AstraZeneca vaccine, currently only given to people aged 60 …

Coronavirus: Oxford study finds AstraZeneca and Pfizer vaccines both prevent asymptomatic cases
3 years, 8 months ago

Coronavirus: Oxford study finds AstraZeneca and Pfizer vaccines both prevent asymptomatic cases

Daily Mail  

Vaccines will allow us to control coronavirus without the need for future lockdowns, the experts behind a major new British study declared last night. The study found that there were significantly more coronavirus cases among people who hadn't been vaccinated than there were in people who had been given jabs or who had had Covid before The longer it had …

Coronavirus | SII CEO appeals to U.S. seeking lifting of embargo on export of raw material for vaccine
3 years, 8 months ago

Coronavirus | SII CEO appeals to U.S. seeking lifting of embargo on export of raw material for vaccine

The Hindu  

Adar Poonawalla, Chief Executive Officer, Serum Institute of India, the world’s biggest vaccine maker, on Friday tweeted an appeal to U.S. President Joe Biden seeking lifting of the embargo on U.S. export of raw materials, which, he said, was affecting its production of COVID-19 shots. Stringent implementation of public health measures along with full community participation by adopting COVID-19 appropriate …

Here’s the impact the Johnson & Johnson pause might have on the Covid-19 vaccine rollout
3 years, 8 months ago

Here’s the impact the Johnson & Johnson pause might have on the Covid-19 vaccine rollout

CNN  

CNN — The pause in Johnson & Johnson’s Covid-19 vaccine rollout could have a significant impact on the US – but not in the way you might think. “It’s a low frequency problem but with potentially big consequences for the vaccine program if not put into the proper context,” said Dr. Arnold Monto, acting chair of an FDA vaccine advisory …

Ministers 'consider coronavirus vaccine rethink' after AstraZeneca chaos
3 years, 8 months ago

Ministers 'consider coronavirus vaccine rethink' after AstraZeneca chaos

Dutch News  

The government will announce if there is to be a change in the vaccination strategy at Tuesday’s press conference, following widespread criticism of the approach to the AstraZeneca vaccine, broadcaster NOS said on Monday evening. Last week health minister Hugo de Jonge said the Netherlands would stop using the AstraZeneca vaccine on the under 60s because of the risk of …

WHO chief laments 'shocking imbalance' in Covid-19 shot distribution
3 years, 9 months ago

WHO chief laments 'shocking imbalance' in Covid-19 shot distribution

Hindustan Times  

There is a "shocking imbalance" in the distribution of Covid-19 vaccines worldwide and most countries do not have anywhere near enough shots to cover health workers and others at high-risk, WHO Director-General Tedros Adhanom Ghebreyesus said on Friday. The COVAX facility has delivered nearly 38.4 million doses of Covid-19 vaccines to 102 countries across six continents, six weeks after it …

Government vaccine advisors say they don’t foresee AstraZeneca vaccine being used in the US
3 years, 9 months ago

Government vaccine advisors say they don’t foresee AstraZeneca vaccine being used in the US

CNN  

CNN — Vaccine advisers to the federal government tell CNN they don’t foresee AstraZeneca’s Covid-19 vaccine being used in the United States, and even if it were offered, they personally wouldn’t take it, given the other available options. Dr. Anthony Fauci told CNN Wednesday that even if the US Food and Drug Administration granted emergency use authorization to AstraZeneca’s vaccine, …

How AstraZeneca’s latest vaccine troubles could slow the global recovery
3 years, 9 months ago

How AstraZeneca’s latest vaccine troubles could slow the global recovery

CNN  

London CNN Business — AstraZeneca’s vaccine is key to ending the global economic slump caused by the coronavirus. The World Health Organization said in a statement Wednesday that “based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.” AstraZeneca said that nearly 200 million …

AstraZeneca vaccine: A timeline of the coronavirus jab under investigation over links to blood clots
3 years, 9 months ago

AstraZeneca vaccine: A timeline of the coronavirus jab under investigation over links to blood clots

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. 9 November 2020 Pfizer beats AZ to become the first major pharmaceutical company to announce …

AstraZeneca Covid vaccine possibly linked to rare blood clots: EU drug regulator
3 years, 9 months ago

AstraZeneca Covid vaccine possibly linked to rare blood clots: EU drug regulator

Hindustan Times  

The EU’s drug regulator on Wednesday said that the reported cases of blood clotting should be listed as a possible side effect of AstraZeneca's vaccine against the coronavirus disease. Last week, the UK’s medicine regulator confirmed the death of seven individuals from unusual blood clots after they were administered with AstraZeneca vaccine. Several European countries have temporarily suspended the use …

Oxford Pauses Trial of AstraZeneca Covid-19 Vaccine in Children as Clot Link Gets Probed
3 years, 9 months ago

Oxford Pauses Trial of AstraZeneca Covid-19 Vaccine in Children as Clot Link Gets Probed

News 18  

A British trial of the AstraZeneca coronavirus vaccine on children has been paused, Oxford University said Tuesday, as global regulators rush to assess its possible link to rare blood clots in adults. The university, which helped develop the embattled vaccine, said in a statement that there were “no safety concerns” in the trial, but acknowledged fears over a potential link …

AstraZeneca vaccine comes under further pressure in EU, UK
3 years, 9 months ago

AstraZeneca vaccine comes under further pressure in EU, UK

Al Jazeera  

While the EMA says ‘possible link’ found between the jab and ‘unusual’ blood clots, the UK offers young people alternative shot due to risks. The embattled AstraZeneca COVID-19 vaccine came under further pressure on Wednesday, as the European Union’s medicines regulator found a possible link between the shot and rare cases of blood clots, while the United Kingdom announced it …

European Medicines Agency: Rare clots possibly linked to AstraZeneca shot
3 years, 9 months ago

European Medicines Agency: Rare clots possibly linked to AstraZeneca shot

India Today  

The EU's drug regulator says it has found a “possible link” between the AstraZeneca coronavirus vaccine and a rare clotting disorder but said that the benefits of the shot still outweigh risks. In a statement released Wednesday, the European Medicines Agency placed no new restrictions on using the vaccine in people 18 and over. Experts reviewed several dozen cases that …

European countries consider mixing COVID-19 vaccines because of AstraZeneca concerns
3 years, 9 months ago

European countries consider mixing COVID-19 vaccines because of AstraZeneca concerns

ABC  

Several European countries are considering mixing COVID-19 vaccines for citizens who received a first dose of AstraZeneca's shot, an unprecedented move highlighting the challenge for governments struggling to tame rising infections. Key points: Concerns over the safety of the AstraZeneca vaccine have led to countries pausing their rollout Some people who received their first COVID-19 shot, are no longer eligible …

AstraZeneca Covid-19 vaccine risk-benefit 'still largely positive': WHO
3 years, 9 months ago

AstraZeneca Covid-19 vaccine risk-benefit 'still largely positive': WHO

Hindustan Times  

The risk-benefit balance for the AstraZeneca Covid-19 vaccine is "still largely positive", the World Health Organization said Tuesday after fresh claims about links to blood clots. A man receives a dose of AstraZeneca COVID-19 vaccine at a vaccination center, amid the coronavirus disease outbreak, in Ronquieres, Belgium April 6, 2021. "The appraisal we have for the moment -- and this …

UK Oxford-AstraZeneca COVID vaccine trial in children paused
3 years, 9 months ago

UK Oxford-AstraZeneca COVID vaccine trial in children paused

Al Jazeera  

Oxford University says there were ‘no safety concerns’ in the trial but will await additional data before restarting. The University of Oxford said on Tuesday it had paused a small UK trial testing the COVID-19 vaccine it developed with AstraZeneca in children and teenagers, as it waits for more data on rare blood clotting issues in adults who received the …

Thrombosis experts angered by stop of AstraZeneca vaccine
3 years, 9 months ago

Thrombosis experts angered by stop of AstraZeneca vaccine

NL Times  

Thrombosis experts are baffled as to why the decision to stop with the AstraZeneca vaccine on Saturday was reached based on incomplete information and without their consultation, the Volkskrant reports. “I’m getting continuously more enraged at how this happened.” Expert on vascular diseases, Pieter Willem Kamphuisen, believes the decision was made prematurely and not based on scientific evidence. You must …

UK regulator reports 30 clot cases linked to AstraZeneca jab
3 years, 9 months ago

UK regulator reports 30 clot cases linked to AstraZeneca jab

India TV News  

Britain’s medicines regulator said it has identified 30 cases of rare blood clot events associated with the AstraZeneca coronavirus vaccine but stressed the benefits “continue to outweigh any risks.” The Medicines and Healthcare Regulatory Agency said the risk associated with this type of blood clot is “very small” and that the public should continue to take up the vaccine when …

EU says ‘no evidence’ to restrict use of AstraZeneca’s COVID-19 vaccine
3 years, 9 months ago

EU says ‘no evidence’ to restrict use of AstraZeneca’s COVID-19 vaccine

LA Times  

The head of the European Union’s drugs regulator says there is “no evidence” that would support restricting the use of AstraZeneca’s COVID-19 vaccine in any population, as Germany and a handful of other European countries have done amid concerns over rare blood clots in people who got the shot. World & Nation What we know about AstraZeneca blood clot reports …

AstraZeneca revises COVID-19 vaccine efficacy to 76% after US panel flags issues
3 years, 9 months ago

AstraZeneca revises COVID-19 vaccine efficacy to 76% after US panel flags issues

Firstpost  

The revised figures comes a day after an independent panel in the US accused AstraZeneca of cherry-picking data in determining the protection offered by its vaccine Washington: AstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its disputed US study, the latest in an extraordinary public rift with American officials. Some experts said the …

AstraZeneca and Pfizer coronavirus vaccines should be deferred for small group of Australians amid blood clot concerns, advisory group says
3 years, 9 months ago

AstraZeneca and Pfizer coronavirus vaccines should be deferred for small group of Australians amid blood clot concerns, advisory group says

ABC  

Australia’s expert advisory group on vaccines has recommended the COVID-19 vaccine be deferred for people who have a history of specific rare blood clotting disorders. Key points: ATAGI says it has made the recommendation as a "precautionary" measure The recommendation follows concerns from Europe about blood clots post vaccination Experts are waiting for more European data before making their next …

AstraZeneca lowers COVID-19 vaccine efficacy slightly to 76% after U.S. criticism
3 years, 9 months ago

AstraZeneca lowers COVID-19 vaccine efficacy slightly to 76% after U.S. criticism

LA Times  

AstraZeneca reported a slightly lower efficacy rate for its COVID-19 vaccine after the results of an American clinical trial were criticized as outdated, raising further questions over the controversial shot and whether it will be approved in the U.S. The company said the shot was 76% effective in its U.S. trial in a statement Thursday, after an independent monitoring board …

US health officials say AstraZeneca may have included 'outdated information' in coronavirus vaccine trial
3 years, 9 months ago

US health officials say AstraZeneca may have included 'outdated information' in coronavirus vaccine trial

ABC  

AstraZeneca may have included "outdated information" in touting the effectiveness of its COVID-19 vaccine in a US study, federal health officials have said, in an unusual public rift that could further erode confidence in the shot. Key points: AstraZeneca released the result of a 32,000-person study in the US to measure the effectiveness of its vaccine But an independent panel …

AstraZeneca accused of cherry-picking vaccine study data
3 years, 9 months ago

AstraZeneca accused of cherry-picking vaccine study data

Associated Press  

WASHINGTON — AstraZeneca may have included “outdated information” in touting the effectiveness of its COVID-19 vaccine in a U.S. study, federal health officials said Tuesday in an unusual public rift that could further erode confidence in the shot. But shortly after midnight, the National Institutes of Health issued a statement saying the independent monitors that oversee the study had “expressed …

AstraZeneca vaccine: Independent review board raises concerns about trial data
3 years, 9 months ago

AstraZeneca vaccine: Independent review board raises concerns about trial data

CNN  

CNN — In an unusual statement released early Tuesday, the National Institute of Allergy and Infectious Diseases said the independent board that reviews data from multiple Covid-19 vaccine candidates has raised concerns about AstraZeneca’s announcement of efficacy data from its vaccine trial. “The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided …

AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board
3 years, 9 months ago

AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board

NPR  

AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board Enlarge this image toggle caption Matthias Schrader/AP Matthias Schrader/AP A safety board overseeing AstraZeneca's COVID-19 vaccine trial is raising concerns about the company's data. If the pharmaceutical company did include outdated information from that trial, that could provide an "incomplete view of the efficacy data," the NIAID said. The pharmaceutical company …

It’s been declared safe and effective. But missteps dog AstraZeneca’s COVID vaccine
3 years, 9 months ago

It’s been declared safe and effective. But missteps dog AstraZeneca’s COVID vaccine

LA Times  

AstraZeneca’s release of encouraging data Monday about its COVID-19 vaccine from its U.S. trial raised hopes that the drug company could bury doubts about the shot and put a troubled rollout behind it. But hours later, U.S. officials issued an unusual statement expressing concern that the company had included “outdated information” from its study and that it may have provided …

AstraZeneca vaccine trial results may have included outdated info, U.S. officials say
3 years, 9 months ago

AstraZeneca vaccine trial results may have included outdated info, U.S. officials say

LA Times  

AstraZeneca may have included “outdated information” in touting the effectiveness of its COVID-19 vaccine in a U.S. study, federal health officials said Tuesday in an unusual public rift that could further erode confidence in the shot. But shortly after midnight, the National Institutes of Health issued a statement saying the independent monitors that oversee the study had “expressed concern that …

Oxford-AstraZeneca Vaccine Effective Against Severe Covid-19, New Trial in US Confirms
3 years, 9 months ago

Oxford-AstraZeneca Vaccine Effective Against Severe Covid-19, New Trial in US Confirms

News 18  

A large trial in the US and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent effectiveness in stopping severe disease and hospitalisation, the biotech firm said on Monday. The vaccine’s efficacy was consistent across ethnicity and age, and in participants aged 65 years and over, …

U.S. data shows AstraZeneca’s vaccine is effective for all ages
3 years, 9 months ago

U.S. data shows AstraZeneca’s vaccine is effective for all ages

The Hindu  

A phase 3 trial of the AstraZeneca vaccine candidate in the United States has revealed an efficacy of 79%, when both doses were administered 4 weeks apart. ‘No safety concerns’ The U.S. trial, which recruited over 32,000 volunteers across all age groups, showed that the vaccine is 79% effective against symptomatic COVID-19, and 100% effective against severe, or critical symptomatic …

European Trust In AstraZeneca Vaccine Falls, Opinion Poll Says
3 years, 9 months ago

European Trust In AstraZeneca Vaccine Falls, Opinion Poll Says

News 18  

Fewer Europeans trust the AstraZeneca COVID-19 vaccine after several countries reported side-effects, such as blood clots, an opinion poll by YouGov showed on Monday, even though scientific studies have found it is safe and effective. An increased number of French, German, Italian, and Spanish adults said they considered the vaccine unsafe, YouGov found, although faith in other vaccines by Pfizer …

AstraZeneca Vaccine Can Prevent COVID-19, Late-Stage Study Says
3 years, 9 months ago

AstraZeneca Vaccine Can Prevent COVID-19, Late-Stage Study Says

NPR  

AstraZeneca Vaccine Can Prevent COVID-19, Late-Stage Study Says Enlarge this image toggle caption Finnbarr Webster/Getty Images Finnbarr Webster/Getty Images Preliminary results from a late-stage study examining the efficacy of the Oxford-AstraZeneca vaccine indicate it is significantly effective at preventing severe illness from COVID-19. Results of the trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered …

The most promising AstraZeneca trial yet - Coronavirus Fact vs. Fiction
3 years, 9 months ago

The most promising AstraZeneca trial yet - Coronavirus Fact vs. Fiction

CNN  

A version of this story appeared in the March 22 edition of CNN’s Coronavirus: Fact vs. Fiction newsletter. CNN — The AstraZeneca vaccine is highly effective in all age and ethnicity groups, prevents all cases of hospitalization and does not trigger blood clots, results from a long-awaited clinical trial in the US, Chile and Peru show, paving the way for …

Discover Related